-
No causal effects of plasma homocysteine levels on the risk of coronary heart disease or acute myocardial infarction: A Mendelian randomization studyL Miao, GX Deng, RX Yin et al. -
Clinical Efficacy and Safety of Alirocumab after Acute Coronary Syndrome According to Achieved Level of Low-Density Lipoprotein Cholesterol: A Propensity Score-Matched Analysis of the ODYSSEY OUTCOMES TrialGG Schwartz, PG Steg, ODYSSEY OUTCOMES Committees and Investigators et al.
-
Myocardial Infarction Risk Stratification With a Single Measurement of High-Sensitivity Troponin IY Sandoval, R Nowak, CR deFilippi et al.
-
Another Nail in the Coffin for Intra-Aortic Balloon Counterpulsion in Acute Myocardial Infarction With Cardiogenic ShockKatz SD, Smilowitz NR, Hochman JS.
-
Linking Spontaneous Coronary Artery Dissection, Cervical Artery Dissection, and Fibromuscular Dysplasia: Heart, Brain, and KidneysParé G, Bhatt DL.
-
Refractory Angina: From Pathophysiology to New Therapeutic Nonpharmacological TechnologiesG Gallone, L Baldetti, G Tzanis et al.
-
Ticagrelor or Prasugrel in Patients with Acute Coronary SyndromesSchüpke S, Neumann FJ, ISAR-REACT 5 Trial Investigators.
-
Application of High-Sensitivity Troponin in Suspected Myocardial InfarctionJT Neumann, R Twerenbold, F Ojeda et al.
http://www.cbsmd.cn Contact us by cbs@cbsmd.cn
Copyright ⓒ CBSMD Nanjing China. All rights reserved.
